Home LiteratureArticle Details
PMID: 11114321 Published · ppublish English Comment Editorial

When and how to treat chronic lymphocytic leukemia.

The New England journal of medicine ·Vol. 343 ·No. 24 ·2000-12-14 ·Pages 1799-801

Dighiero G, Binet JL

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents/therapeutic use Chlorambucil/therapeutic use Humans Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy,mortality,pathology Neoplasm Staging/methods Prognosis Remission Induction Survival Rate Vidarabine/analogs & derivatives,therapeutic use
Chemicals
Antineoplastic Agents Chlorambucil Vidarabine fludarabine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Dighiero G
Binet J L
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
DOI
10.1056/NEJM200012143432410
Published
2000-12-14
Pages
1799-801
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 11114313
External Links
PubMed source DOI: 10.1056/NEJM200012143432410 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2